Abiopharma

🔍 Tschirhart Benjamin Thomas (Executive)

Company: AerSale Corp (ASLE)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Acquired 15,164 shares of Common Stock (Direct)
  Date: 2026-08-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 47,651.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 31,800 shares of Stock Option (right to buy) at $5.77 per share (Derivative)
  Date: 2026-08-19 | Code: A | Expires: 2036-08-19 | equity_swap_involved: 0 | shares_owned_after: 79,352.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents an award of restricted stock units granted under the AerSale Corporation 2020 Equity Incentive Plan, as amended (the "Plan"), that will vest in one-third increments on each of June 7, 2027, June 7, 2028, and June 7, 2029.
• F2: Represents stock options granted under the Plan that will vest in one-third increments on each of June 7, 2027, June 7, 2028, and June 7, 2029.
• REMARKS: Senior Vice President and Head of Engineered Solutions